Today: 19 June 2026

Netflix stock slips after hours as Goldman trims target and Warner deal battle drags on

Netflix stock slips after hours as Goldman trims target and Warner deal battle drags on

Netflix shares fell 1.2% to $89.46 in after-hours trading Friday after Goldman Sachs cut its price target to $112 and maintained a Neutral rating. Warner Bros. Discovery’s board rejected Paramount’s revised bid and reaffirmed its $82.7 billion agreement with Netflix, while Paramount continues to push its $30-per-share cash offer. Investors await Netflix’s January 20 earnings and Paramount’s January 21 tender deadline.
9 January 2026
·
Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet Class C shares rose about 1% to $329.14 in after-hours trading Friday. CEO Sundar Pichai sold 32,500 Class C shares for roughly $10.4 million on Jan. 7, leaving him with over 2.2 million. The company reports quarterly results Feb. 4. EU regulators are expected to rule by Feb. 10 on Alphabet’s $32 billion Wiz acquisition.
9 January 2026
···
Meta stock edges higher after nuclear power deals aimed at AI data centers

Meta stock edges higher after nuclear power deals aimed at AI data centers

Meta shares rose 1.1% to $653.06 in after-hours trading Friday after announcing nuclear power deals to supply its AI data centers. Agreements with Vistra, Oklo, and TerraPower could support up to 6.6 gigawatts of nuclear capacity by 2035. Financial terms were not disclosed. Investors are watching project timelines and permitting.
9 January 2026
······
Amazon stock edges up after-hours as Amazon Pharmacy adds Novo’s Wegovy pill

Amazon stock edges up after-hours as Amazon Pharmacy adds Novo’s Wegovy pill

Amazon shares rose 0.4% after hours to $247.33 following news that Amazon Pharmacy will offer Novo Nordisk’s Wegovy weight-loss pill at $25 per month for insured customers and $149 for cash-pay. The pill, approved by the FDA in December, will be shipped to all 50 states. Investors await Amazon’s Q4 results on Feb. 5 and a key EU digital proposal on Jan. 20.
9 January 2026
····
Apple stock snaps 7-session skid as Evercore lifts target; Apple Card switch looms

Apple stock snaps 7-session skid as Evercore lifts target; Apple Card switch looms

Apple shares rose 0.13% to $259.37 Friday, ending a seven-day losing streak. Evercore raised its price target to $330 and lifted quarterly estimates ahead of Apple’s Jan. 29 results. Apple and Chase set a roughly 24-month timeline to move the Apple Card portfolio from Goldman Sachs. CEO Tim Cook received $74.3 million in 2025 compensation, mostly in stock awards.
9 January 2026
··
Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

Microsoft shares rose 0.2% to $479.07 Friday after launching a Copilot checkout tool and new “agentic AI” features for retailers. The company, now valued at $3.85 trillion, will report fiscal Q2 results after markets close Jan. 28. Wells Fargo cut its price target to $665 but kept an Overweight rating. Some new retail AI features remain in preview, with adoption by merchants still uncertain.
9 January 2026
···
Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar shares fell 5.9% to $20.90 in Friday’s Nasdaq session after the company reported preliminary 2025 retail sales of about 60,119 cars, up 34%, and a 27% rise in fourth-quarter volumes. The company said a December ADS ratio change restored compliance with Nasdaq’s $1 bid-price rule. CEO Michael Lohscheller set Feb. 18 for a strategy update. Europe now accounts for 78% of sales as U.S. tariffs and competition weigh.
9 January 2026
··
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers shares dropped 5.3% to $32.06 after Amazon Pharmacy began offering Novo Nordisk’s Wegovy weight-loss pill. Bank of America cut its price target on Hims, citing margin and spending risks for 2026. The stock fell from an intraday high of $34.35. Investors are watching for signs of pricing pressure and updated forecasts ahead of Hims’ next earnings report.
9 January 2026
··
Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands shares fell 4.3% to $59.25 Friday afternoon, underperforming a rising U.S. market. Analysts cited concerns over Macau operating costs and fourth-quarter margins after Sands China and Melco Resorts dropped sharply in Hong Kong. Other casino stocks with Macau exposure also declined. Investors are watching for the company’s next results update later this month.
9 January 2026
·
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.
9 January 2026
···
Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines shares fell 3.8% to $18.88 Friday after Stifel downgraded the stock to “hold,” citing uncertainty over a pending NASA rover contract. The stock swung between $17.82 and $19.73 on heavy volume. NASA’s Lunar Terrain Vehicle award remains undecided. Investors are also watching for U.S. inflation data on Jan. 13 and company earnings on March 19.
9 January 2026
··
1 … 929 930 931 932 933 … 2,084

Stock Market Today

  • Ford Motor Company (F) Stock Analysis: Is It a Buy Now?
    June 19, 2026, 10:34 AM EDT. Ford Motor Company's (F) stock has dropped 29.5% in the past month, underperforming both the S&P 500 and its automotive peers. Analysts expect Ford's earnings per share to rise 28.2% this quarter, but full-year estimates have declined. The company's Zacks Rank of #3 (Hold) reflects mixed earnings revisions and uncertainty about future performance. Investors should weigh recent earnings estimate trends, revenue growth prospects, and broader industry challenges before deciding if Ford is a buy amid volatile market conditions.

Latest articles

AT&T stock enters Juneteenth break under pressure as California fight widens

AT&T stock enters Juneteenth break under pressure as California fight widens

19 June 2026
AT&T stock slid 5.5% this week to $22.01, closing Thursday at a June low as California regulators moved to block its plan to end copper-wire phone service, raising risks to cost savings and future cash flow just before the Juneteenth market break; investors now await Monday’s trading and the July 22 earnings call.
Go toTop